Protecting Products versus Platforms
Nature Biotechnology, Vol. 34, pp. 462-65
4 Pages Posted: 5 Jun 2016
Date Written: May 1, 2016
Patents have long been the most important legal assets of biotech companies. Increasingly, however, biotech firms find themselves on one side of a divide: as either traditional product companies or platform companies. Given the differences between these two types of business models, the merits of intellectual property (IP) protection vary between them. This article explores how those differences relate to biotech startups and entrepreneurs seeking to protect their inventions.
Keywords: patents, trade secrets, intellectual property, biotechnology, startups
JEL Classification: K00, K23, K41, O3, O34, D23, K11
Suggested Citation: Suggested Citation